Evidence map›Paper›PMID 40715737›Full record

ArticleAging cell2025

Aerobic Exercise Attenuates Autophagy-Lysosomal Flux Deficits via β2-AR-Mediated ESCRT-III Subunit CHMP4B in Mice With Human MAPT P301L.

Shu-Guang Bi, Haitao Yu, Tian-Long Gao, Jia-Jun Wu, Yu-Ming Mao, Juan Gong, Fang-Zhou Wang, Liu Yang, Jia Chen, Zi-Chong Lan and 3 more

Abstract read
In one paragraph

Article in Aging cell, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Shu-Guang BiDepartment of Fundamental Medicine, MOE Medical Basic Research Innovation Center for Gut Microbiota and Chronic Diseases, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.ORCID 0009-0005-9113-151X
Haitao YuDepartment of Fundamental Medicine, MOE Medical Basic Research Innovation Center for Gut Microbiota and Chronic Diseases, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.ORCID 0000-0002-0302-998X
Tian-Long GaoDepartment of Fundamental Medicine, MOE Medical Basic Research Innovation Center for Gut Microbiota and Chronic Diseases, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.
Jia-Jun WuDepartment of Fundamental Medicine, MOE Medical Basic Research Innovation Center for Gut Microbiota and Chronic Diseases, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.
Yu-Ming MaoDepartment of Fundamental Medicine, MOE Medical Basic Research Innovation Center for Gut Microbiota and Chronic Diseases, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.
Juan GongDepartment of Fundamental Medicine, MOE Medical Basic Research Innovation Center for Gut Microbiota and Chronic Diseases, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.
Fang-Zhou WangDepartment of Fundamental Medicine, MOE Medical Basic Research Innovation Center for Gut Microbiota and Chronic Diseases, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.
Liu YangDepartment of Fundamental Medicine, MOE Medical Basic Research Innovation Center for Gut Microbiota and Chronic Diseases, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.
Jia ChenDepartment of Fundamental Medicine, MOE Medical Basic Research Innovation Center for Gut Microbiota and Chronic Diseases, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.
Zi-Chong LanDepartment of Fundamental Medicine, MOE Medical Basic Research Innovation Center for Gut Microbiota and Chronic Diseases, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.
Meng-Ting ShenDepartment of Fundamental Medicine, MOE Medical Basic Research Innovation Center for Gut Microbiota and Chronic Diseases, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.
Yun-Juan NieDepartment of Fundamental Medicine, MOE Medical Basic Research Innovation Center for Gut Microbiota and Chronic Diseases, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.
Gao-Shang ChaiDepartment of Fundamental Medicine, MOE Medical Basic Research Innovation Center for Gut Microbiota and Chronic Diseases, Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China.ORCID 0000-0002-1943-3717

Funding

China Postdoctoral Science Foundation 2020M651491Fundamental Research Funds for the Central Universities JUSRP123070Jiangsu Province Postdoctoral Science Foundation 2020Z037Medical Development Foundation of Jiangnan University YXXK20240926003National Natural Science Foundation of China 81601121National Natural Science Foundation of China 82401671Natural Science Foundation of Jiangsu Province BK20211235Natural Science Foundation of Jiangsu Province BK20231050Postgraduate Research & Practice Innovation Program of Jiangsu Province KYCX25_2775Postgraduate Research & Practice Innovation Program of Jiangsu Province KYCX25_2779Six Talent Peaks Project in Jiangsu Province SZCY-003Youth Talent Support Project of Jiangsu Province for Science and Technology JSTJ-2024-370
6 · The paper itself

Abstract

Deficits in the autophagy-lysosomal pathway facilitate intracellular microtubule associated protein tau (MAPT) accumulation in Alzheimer disease (AD). Aerobic exercise (AE) has been recommended as a way to delay and treat AD, but the exact effects and mechanisms have not been fully elucidated. Here, we found that AE (8-week treadmill running, 40 min/day, 5 days/week) alleviated autophagy-lysosomal defects and MAPT pathology through the activation of β2-adrenergic receptors (β2-AR) in MAPT P301L mice. Molecular mechanistic investigations revealed that endosomal sorting complex required for transport (ESCRT) III subunit charged multivesicular body protein 4B (CHMP4B), which is essential for autophagosome-lysosome fusion, was significantly decreased in the cerebral cortex of AD patients and the hippocampus of MAPT P301L mice. AE restored the levels of CHMP4B, which reversed autophagy-lysosomal defects and reduced MAPT aggregation. Inhibition of β2-AR by propranolol (30 mg/kg, intragastric administration 1 h before each AE session) restrained AE-attenuated MAPT accumulation by inhibiting autophagy-lysosomal flux in MAPT P301L mice. Our findings suggest that AE can alleviate autophagosome-lysosome fusion deficits by promoting the β2-AR-RXRα-CHMP4B-ESCRT-III pathway, reducing pathological MAPT aggregation, which also reveals a novel theoretical basis for AE attenuating AD progression.

Indexed as

AutophagyEndosomal Sorting Complexes Required for TransportLysosomesPhysical Conditioning, AnimalReceptors, Adrenergic, beta-2tau ProteinsAlzheimer DiseaseAnimalsHumansMaleMiceMice, TransgenicEndosomal Sorting Complexes Required for TransportMAPT protein, humanReceptors, Adrenergic, beta-2tau Proteinsaerobic exerciseAlzheimer diseaseautophagyCHMP4BMAPTβ2‐adrenergic receptor

Identifiers

PMID40715737
PMCPMC12507411

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.